Marblegate Capital Corporation MGTE
0.94
(0.06)
(6.00%)
as of 24 Sep
- Market cap
- $406.3M
- P/E
- 41.8×
Follow MGTE
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(18.26%) | (15.67%) | (14.88%) | 0.21% | |
| (15.56%) | (6.49%) | (12.01%) | 0.37% | ||
ROIC |
0.74% | 0.08% | (0.18%) | (0.96%) | |
Return on Tangible Assets |
(184.91%) | (239.60%) | (100.55%) | 19.66% | |
Average Days of Receivables |
38.88 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.30) | (0.53) | (0.71) | (0.74) | |
Free Cash Flow |
(22.24) | (37.73) | (52.65) | (54.64) | |
Capital Expenditures |
(21.49) | (38.90) | (45.22) | (46.67) | |
Piotroski F-Score |
1.00 | 1.00 | 1.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
(0.12%) | 0.18% | (1.16%) | (1.23%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
— | — | — | 0.00 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
— | — | — | 0.00 | |
Days of Inventory on Hand |
— | — | — | 0.00 | |
Tax Rate |
(498.13) | (5.37) | (5.47) | (0.67) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
72.02% | 91.47% | 84.65% | 86.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.01 | (0.03) | 0.18 | (6.16) | |
Depreciation/Fixed assets |
0.12 | 5.82 | 0.11 | 10.81 | |
Capex/Depreciation |
(8.32) | (11.68) | (10.07) | (7.65) | |
Revenue per Share |
0.67 | 0.68 | 0.79 | 0.77 | |
Operating CF per Share |
(0.01) | 0.02 | (0.10) | (0.11) | |
Capex per Share |
(0.29) | (0.55) | (0.61) | (0.63) | |
Capex to Sales |
0.43 | 0.80 | 0.78 | 0.82 | |
Net Profit Margin |
(104.13%) | (92.61%) | (73.06%) | 2.27% |
Columns are period end dates